These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 14654924)

  • 1. Hypomagnesemia associated with chemotherapy in patients treated for acute lymphoblastic leukemia: possible mechanisms.
    Guo CY; Halton JM; Barr RD; Atkinson SA
    Oncol Rep; 2004 Jan; 11(1):185-9. PubMed ID: 14654924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
    Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
    Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study.
    Wiernikowski JT; Barr RD; Webber C; Guo CY; Wright M; Atkinson SA
    J Oncol Pharm Pract; 2005 Jun; 11(2):51-6. PubMed ID: 16460605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
    Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
    Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of bone metabolism in children with acute lymphoblastic leukemia after induction chemotherapy treatment.
    Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Koliouskas D; Papastergiou C; Tsituridis I
    Pediatr Hematol Oncol; 2005 Jun; 22(4):285-9. PubMed ID: 16020115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: influence of disease, drugs and nutrition.
    Atkinson SA; Halton JM; Bradley C; Wu B; Barr RD
    Int J Cancer Suppl; 1998; 11():35-9. PubMed ID: 9876475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal morbidity in childhood acute lymphoblastic leukemia.
    Mandel K; Atkinson S; Barr RD; Pencharz P
    J Clin Oncol; 2004 Apr; 22(7):1215-21. PubMed ID: 15051768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
    Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N
    Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia.
    van der Sluis IM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM
    J Pediatr; 2002 Aug; 141(2):204-10. PubMed ID: 12183715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of bone mineral density and risk factors in children completing treatment for acute lymphoblastic leukemia.
    Gunes AM; Can E; Saglam H; Ilçöl YO; Baytan B
    J Pediatr Hematol Oncol; 2010 Apr; 32(3):e102-7. PubMed ID: 20216235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bone mineral density in children before and after completion of cancer treatment].
    Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M; Kaczmarski M; Piotrowska-Jastrzebska J
    Pol Merkur Lekarski; 2004 Jul; 17(97):37-42. PubMed ID: 15559608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
    van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of bone mineral density at different phases of therapy of childhood all.
    Maniadaki I; Stiakaki E; Germanakis I; Kalmanti M
    Pediatr Hematol Oncol; 2006; 23(1):11-8. PubMed ID: 16326407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
    Gonc EN; Kandemir N
    Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RANKL:osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis.
    Rouster-Stevens KA; Langman CB; Price HE; Seshadri R; Shore RM; Abbott K; Pachman LM
    Arthritis Rheum; 2007 Mar; 56(3):977-83. PubMed ID: 17328075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total body bone measurements: a cross-sectional study in children with acute lymphoblastic leukemia during and following completion of therapy.
    Kelly KM; Thornton JC; Hughes D; Osunkwo I; Weiner M; Wang J; Horlick M
    Pediatr Blood Cancer; 2009 Jan; 52(1):33-8. PubMed ID: 18816694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of bony morbidity in children with acute lymphoblastic leukemia.
    Rayar MS; Nayiager T; Webber CE; Barr RD; Athale UH
    Pediatr Blood Cancer; 2012 Jul; 59(1):77-82. PubMed ID: 22190454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mass and bone mineral metabolism at diagnosis and after intensive treatment in children with acute lymphoblastic leukemia.
    Swiatkiewicz V; Wysocki M; Odrowaz-Sypniewska G; Koltan A; Manysiak S; Dylewska K
    Med Pediatr Oncol; 2003 Dec; 41(6):578-80. PubMed ID: 14595724
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemia.
    Hartman A; te Winkel ML; van Beek RD; de Muinck Keizer-Schrama SM; Kemper HC; Hop WC; van den Heuvel-Eibrink MM; Pieters R
    Pediatr Blood Cancer; 2009 Jul; 53(1):64-71. PubMed ID: 19283791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral density in postmenarchal adolescent girls in the United States: associated biopsychosocial variables and bone turnover markers.
    Harel Z; Gold M; Cromer B; Bruner A; Stager M; Bachrach L; Wolter K; Reid C; Hertweck P; Nelson A; Nelson D; Coupey S; Johnson C; Burkman R; Bone H
    J Adolesc Health; 2007 Jan; 40(1):44-53. PubMed ID: 17185205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.